Under current rules, the Medicare GLP-1 Bridge Program is scheduled to run through December 31, 2027 , unless its extended or replaced
This is a genuine safety issue
This can make it harder to lose weight and may also trigger cravings that undo your progress
is supported by a Banting and Best Diabetes Centre Novo Nordisk Chair in Incretin biology and a Sinai Health Novo Nordisk Foundation Fund in Regulatory Peptides as well as Canadian Institute for Health Research (CIHR) grant 192044
In the rest of this letter for StayCurious Metabolism Premium members, we will dive into: How people are using tesamorelin in the real world (biohackers, Silicon Valley, etc.) Dosing and protocols , including frequency, cycling, timing, and what to track to optimize benefits while minimizing risk